ACE polymorphism does not determine short-term renal response to ACE-inbibition in proteinuric patients

Nephrology Dialysis Transplantation

Volumn 12, Issue SUPPL. 2, 1997, Pages 42-46

  Van Der Kleij, F G H ^a   Navis, G J ^a,b   Gansevoort, R T ^a   Heeg, J E ^a   Scheffer, H ^a   De Zeeuw, D ^a   De Jong, P E ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

ACE; ACE inhibition; Chronic renal failure; Genetics; Polymorphism; Proteinuria

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LISINOPRIL;

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; DNA POLYMORPHISM; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PROTEINURIA;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; ENALAPRIL; FEMALE; GENOTYPE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY DISEASES; LISINOPRIL; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PROTEINURIA; TIME FACTORS;

EID: 0030837677     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D. Reduction of proteinuria by angiotensin converting enzyme inhibition. Kidney Int 1987; 32: 78-82
2. Maschio G, Alberti D, Janin G et al. Effect of the angiotensin converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996; 334: 939-945
3. Bedogna V, Valvo E, Casagrande P et al. Effects of ACE inhibition in normotensive patients with chronic glomerular disease and normal renal function. Kidney Int 1990; 38: 101-107
4. Praga M, Hernandez E, Montoyo C, Andrés A, Ruilope LM, Rodicio JL. Long term beniftcial effects of angiotensin converting enyme inhibition by lisinopril. Kidney Int 1989; 36: 272-279
5. Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D. Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int 1989; 36: 272-279
6. Gansevoort RT, de Zeeuw D, de Jong PE. Additive antiproteinuric effect of ACE inhibition and a low protein diet in human renal disease. Nephrol Dial Transplant 1995; 10: 497-504
7. Gansevoort RT, de Zeeuw D, de Jong PE. Long-term benifits of the anti-proteinuric effect of ACE-inhibition in non-diabetic renal disease. Am J Kidney Dis 1993; 2: 202-206
8. Cambien F, Poirier O, Lecerf I et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-644
9. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion deletion polymorphism in the angiotensin I converting enzyme gene accounts for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346
10. Danser JAH, Schalekamp MADH, Bax WA, et al. Angiotensin-converting-enzyme in the human heart: effect of the insertion/ deletion polymorphism. Circulation 1995; 92: 1387-1388
11. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993; 290: 33-40
12. Donker AJM, van der Hem GK, Sluiter WJ, Beekhuis H. A radioisotope method for simultaneously determination of the glomerular filtration rate and effective renal plasma flow. Neth J Med 1977, 20: 97-103
13. Watanabe N, Kamei S, Ohkubo A, Yamanake M et al. Urinary protein as measured with a pyrogallol red-molybdate complex, manually and in a Hitachi 726 automated analyzer, Clin Chem 1986; 32: 1551-1554
14. Shanmugam W, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR Meth Appl 1993; 3: 120-121
15. Schmidt S, van Hooft IM, Grobbee DE, Ganten D, Ritz E. Polymorphisms of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch hypertension and offspring study. J Hypertens 1993; 11: 345-348
16. Apperloo AJ, de Zeeuw D, de Jong PE. Discordant effects of enalapril and lisinopril on systemic and renal haemodynamics. Clin Pharmacol Ther 1994; 56: 647-658
17. Yoshida H, Mitarai T, Kawamura T et al. Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 1995; 96: 2162-2169
18. Moriyama T, Kitamara H, Ochi S et al. Association of angiotensin I-converting enzyme gene polymorphism with susceptibility to antiproteinuric effect of angiotensin I-converting enzyme inhibitors in patients with proteinuria. J Am Soc Nephrol 1995; 6: 1674-1678
19. Todd GP, Chadwick IG, Higgins KS, Yeo WW, Jackson PR, Ramsay LE. Relation between changes in blood pressure and serum ACE activity after a single dose of enalapril and ACE genotype in healthy subjects. Br J Clin Pharmacol 1995; 39: 131-134
20. Hingorani AD, Jia H, Stevens PA, Hopper R, Dickerson JEC, Brown MJ. Renin angiotensin system gene polymorphisms influence blood pressure and response to angiotensin converting enzyme inhibition. J Hyp 1995; 13: 1602-1609
21. Dieguez-Lucena JL, Aranda-Lara P, Ruiz-Galdón M, Garcia-Villanova J, Morrel-Ocana M, Reyes-Engel A. Angiotensin I-converting enzyme genotypes and angiotensin II receptors. Response to therapy. Hypertension 1996; 28: 98-103
22. Harden PN, Geddes C, Rowe PA et al. Polymorphism in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet 1995; 345 (8964): 540-1542
23. Hunley TE, Julian BA, Phillips III JA et al. Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 1996; 49: 571-577
24. Jacobsen P, Tarnow L, Rossing P et al. The insertion/deletion polymorphism in the Angiotensin I-Converting Enzyme (ACE) gene predicts the progression of diabetic nephropathy during ACE inhibition (ACEi) in insulin dependent diabetic (IDDM) patients. J Am Soc Nephrol 1995; 6: 450
25. Yoshida H, Kuriyama S, Atsumi Y et al. Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 1996; 50: 657-664
26. van Essen GG, Rensma PL, de Zeeuw D et al. Association between angiotensin- converting-enzyme and failure of renoprotective therapy, Lancet 1996; 347: 94-95